findmyKOL
Clinical trialNCT06892379RecruitingPhase 1Interventional

A Study of HS-20110 in Participants With Advanced Solid Tumors

SponsorHansoh BioMedical R&D CompanyEnrollment475Solid Tumors
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China
  • Sun Yat-Sen University Cancer Center

    Guangzhou, Guangdong, China

    Recruiting
United States
  • Brcr Medical Center Inc

    Tamarac, Florida, United States

    Chintan Gandhi, MD
    Recruiting
  • Fort Wayne Medical Oncology and Hematology

    Fort Wayne, Indiana, United States

    Sunil Babu
    Recruiting
  • Carolina Biooncology Institute

    Huntersville, North Carolina, United States

    John Powderly
    Recruiting
  • the University of Texas Md Anderson Cancer Center

    Houston, Texas, United States

    Siqing Fu, MD
    Recruiting
  • Next Dallas

    Irving, Texas, United States

    Michael Song
    Recruiting
  • Next Oncology

    San Antonio, Texas, United States

    David Somerhalder
    Recruiting
  • Next Virginia

    Fairfax, Virginia, United States

    Alexander Spira
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

HS-20110
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
26 Feb 2025
Primary completion
31 Dec 2026
Completion
30 Sept 2027
Last update posted
20 Apr 2026
Registered enrollment
475
Registry id
NCT06892379

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.